From the Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.
From the Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan
J Biol Chem. 2018 Apr 13;293(15):5705-5714. doi: 10.1074/jbc.RA117.000741. Epub 2018 Feb 22.
The ubiquitin-proteasome system regulates the abundance of many cellular proteins by mediating their targeted degradation. We previously developed a method-differential proteomics-based identification of ubiquitylation substrates (DiPIUS)-for the comprehensive identification of substrates for a given F-box protein subunit of SCF-type ubiquitin ligases. We have now applied DiPIUS to the F-box protein Fbxw7 in three cell lines (mHepa, Neuro2A, and C2C12) and thereby identified myelin regulatory factor (MyRF), an endoplasmic reticulum-anchored transcription factor that is essential for myelination of nerves in the central nervous system, as a candidate substrate of Fbxw7 specifically in mHepa cells. Co-immunoprecipitation analysis confirmed that the NH-terminal cytoplasmic domain of MyRF interacted with Fbxw7 in these cells. Furthermore, an ubiquitylation assay revealed that MyRF undergoes polyubiquitylation in the presence of purified recombinant SCF In addition, the stability of MyRF in mHepa cells was increased by mutation of a putative phosphodegron sequence or by exposure of the cells to an inhibitor of glycogen synthase kinase-3 (GSK-3). We found that MyRF mRNA is not restricted to the central nervous system but is instead distributed widely among mouse tissues. Furthermore, with the use of RNA sequencing in mHepa cells overexpressing or depleted of MyRF, we identified many novel potential target genes of MyRF. Our results thus suggest that Fbxw7 controls the transcription of MyRF target genes in various tissues through regulation of MyRF protein stability in a manner dependent on MyRF phosphorylation by GSK-3.
泛素-蛋白酶体系统通过介导靶蛋白的降解来调节许多细胞蛋白的丰度。我们之前开发了一种基于差异蛋白质组学的鉴定泛素化底物的方法(DiPIUS),用于全面鉴定特定 SCF 型泛素连接酶 F-box 蛋白亚基的底物。我们现在已经将 DiPIUS 应用于三个细胞系(mHepa、Neuro2A 和 C2C12)中的 F-box 蛋白 Fbxw7,从而鉴定出髓鞘调节因子(MyRF)作为 Fbxw7 在 mHepa 细胞中的候选底物。免疫共沉淀分析证实,MyRF 的 NH2 端细胞质结构域与这些细胞中的 Fbxw7 相互作用。此外,泛素化分析表明,MyRF 在存在纯化的重组 SCF 的情况下发生多泛素化。此外,通过突变假定的磷酸降解序列或使细胞暴露于糖原合酶激酶-3(GSK-3)抑制剂,mHepa 细胞中 MyRF 的稳定性增加。我们发现 MyRF mRNA 不仅局限于中枢神经系统,而是广泛分布于小鼠组织中。此外,在过表达或耗尽 MyRF 的 mHepa 细胞中使用 RNA 测序,我们鉴定出许多 MyRF 的潜在新靶基因。我们的结果表明,Fbxw7 通过 GSK-3 依赖性 MyRF 磷酸化调节 MyRF 蛋白稳定性,从而控制各种组织中 MyRF 靶基因的转录。